Protein Logic, a leading brand in the field of personalized medicine, brings you ImmiPrint® - a revolutionary diagnostic technology platform. By leveraging machine learning, ImmiPrint® detects non-obvious diagnostic patterns in soluble immune proteins in the blood and other body fluids. These patterns create unique signatures that indicate the presence, stage, and potential response to treatment of various diseases.

The technology has already received clinical validation for a signature in blood that effectively rules out Active Tuberculosis (TB), meeting the stringent criteria set by the World Health Organization. TB, along with HIV/AIDS, is among the most significant infectious diseases globally, making early and accurate diagnosis crucial for its control. Besides the TB diagnostic test, Protein Logic is also developing other ImmiPrint® signatures for infectious, autoimmune, and inflammatory diseases.

Stay updated with ProteinLogic's latest advancements in the field by visiting their website